abstract |
The invention provides a compound of formula (I): and pharmaceutically acceptable salts, enantiomers, stereoisomers, rotamers, tautomers, diastereomers or racemates thereof. Also provided are pharmaceutical compositions containing these compounds and methods of using these compounds and compositions to treat diseases or conditions mediated by CDK9. |